Amphastar Pharmaceuticals Q2 2025 Earnings Preview

2 hours ago 1

Amphastar Pharmaceuticals (NASDAQ:AMPH) is scheduled to announce Q2 earnings results on Thursday, August 7th, after market close.
The consensus EPS Estimate is $0.74 (-21.3% Y/Y) and the consensus revenue estimate is $173.24M (-5.0% Y/Y).
Over the last 2 years, AMPH

Recommended For You